Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Oct;74(4):1375–1383. doi: 10.1172/JCI111548

Catabolism of very low density lipoproteins in experimental nephrosis.

D W Garber, B A Gottlieb, J B Marsh, C E Sparks
PMCID: PMC425305  PMID: 6480830

Abstract

The effects of experimental nephrosis in rats, produced by puromycin aminonucleoside, include an elevation of plasma levels of all lipoprotein density classes and the appearance of high density lipoprotein (HDL) rich in apoprotein (apo) A-I and deficient in apo A-IV and apo E. The hyperlipoproteinemia is associated with an increase in hepatic synthesis of lipoproteins. The possible role of decreased very low density lipoprotein (VLDL were obtained from nonfasting animals by ultracentrifugation at d 1.006 and included chylomicrons) catabolism and its relationship to the apolipoprotein composition of nephrotic high density lipoproteins (1.063 less than d less than 1.210, or 1.072 less than d less than 1.210 [HDL]) was explored. When 125I-VLDL was injected, the faster plasma clearance of lower molecular weight apolipoprotein B (apo BL) compared with that of higher molecular weight apo BH which is seen in normal rats was not observed in nephrotic rats. Less labeled phospholipid, apo C, and apo E were transferred from VLDL to higher lipoprotein density classes. Heparin-releasable plasma lipoprotein lipase and hepatic lipase activities were decreased by 50% in nephrotic rats compared with pair-fed controls. Perfusion of livers with medium that contained heparin released 50% less lipase activity in nephrotic rats than in controls. When heparin was injected intravenously, significant decreases in plasma levels of triglycerides and significant increases in levels of free fatty acids were observed in both groups of animals. In the nephrotic rats, 86% of the free fatty acids were in the lipoprotein fractions, as compared with 16% in the controls. Heparin treatment did not restore to normal the decreased apo BL clearance in nephrotic rats but it produced an increased amount of apo A-IV and apo E in the plasma HDL. In vitro addition of partially pure lipoprotein lipase to whole serum from nephrotic rats significantly increased the content of apo E in HDL. We conclude that the abnormal apoprotein composition of HDL in experimental nephrosis is the result of altered entry of apolipoproteins from triglyceride-rich lipoproteins, probably because of decreased lipolysis.

Full text

PDF
1375

Images in this article

1379Image
on p.1379
1379Image
on p.1379
1379Image
on p.1379
1379Image
on p.1379
1379Image
on p.1379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbeeny C. M., Edelstein D., Freedman S. R., Eder H. A. Serum lipoproteins of diabetic rats fed a high cholesterol diet. Diabetes. 1980 Oct;29(10):774–777. doi: 10.2337/diacare.20.10.774. [DOI] [PubMed] [Google Scholar]
  2. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  3. Bar-On H., Chen Y. D., Reaven G. M. Evidence for a new cause of defective plasma removal of very low density lipoproteins in insulin-deficient rats. Diabetes. 1981 Jun;30(6):496–499. doi: 10.2337/diab.30.6.496. [DOI] [PubMed] [Google Scholar]
  4. Bar-On H., Eisenberg S. The metabolic fate of high density lipoprotein (HDL) in the diabetic rat. Diabetologia. 1978 Jan 14;14(1):65–69. doi: 10.1007/BF00429710. [DOI] [PubMed] [Google Scholar]
  5. Bilheimer D. W., Eisenberg S., Levy R. I. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972 Feb 21;260(2):212–221. doi: 10.1016/0005-2760(72)90034-3. [DOI] [PubMed] [Google Scholar]
  6. Blum C. B. Dynamics of apolipoprotein E metabolism in humans. J Lipid Res. 1982 Dec;23(9):1308–1316. [PubMed] [Google Scholar]
  7. Calandra S., Gottardi E., Tarugi P. Plasma post-heparin lipolytic activity in rats with nephrotic syndrome. Horm Metab Res. 1983 Jul;15(7):361–361. doi: 10.1055/s-2007-1018723. [DOI] [PubMed] [Google Scholar]
  8. DRABKIN D. L., MARSH J. B., BRAUN G. A. Amino acid mobilization in plasma protein biosynthesis in experimental nephrosis. Metabolism. 1962 Sep;11:967–977. [PubMed] [Google Scholar]
  9. DUNCOMBE W. G. THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA. Clin Chim Acta. 1964 Feb;9:122–125. doi: 10.1016/0009-8981(64)90004-x. [DOI] [PubMed] [Google Scholar]
  10. DeLamatre J. G., Hoffmeier C. A., Lacko A. G., Roheim P. S. Distribution of apolipoprotein A-IV between the lipoprotein and the lipoprotein-free fractions of rat plasma: possible role of lecithin:cholesterol acyltransferase. J Lipid Res. 1983 Dec;24(12):1578–1585. [PubMed] [Google Scholar]
  11. Doumas B. T., Watson W. A., Biggs H. G. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta. 1971 Jan;31(1):87–96. doi: 10.1016/0009-8981(71)90365-2. [DOI] [PubMed] [Google Scholar]
  12. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  13. GUTMAN A., SHAFRIR E. ADIPOSE TISSUE IN EXPERIMENTAL NEPHROTIC SYNDROME. Am J Physiol. 1963 Oct;205:702–706. doi: 10.1152/ajplegacy.1963.205.4.702. [DOI] [PubMed] [Google Scholar]
  14. Glick J. M., Adelman S. J. Established cell lines from rat adipose tissue that secrete lipoprotein lipase. In Vitro. 1983 May;19(5):421–428. doi: 10.1007/BF02619559. [DOI] [PubMed] [Google Scholar]
  15. Kashyap M. L., de Mendoza S. G., Campbell M., Chen C. Y., Lutmer R. F., Glueck C. J. Lipoprotein lipase activator deficiency in very low density lipoproteins in rat nephrotic syndrome. Experientia. 1978 Aug 15;34(8):1044–1045. doi: 10.1007/BF01915337. [DOI] [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Lux S. E., John K. M., Brewer H. B., Jr Isolation and characterization of apoLp-Gln-II (apoA-II), a plasma high density apolipoprotein containing two identical polypeptide chains. J Biol Chem. 1972 Dec 10;247(23):7510–7518. [PubMed] [Google Scholar]
  18. MALMENDIER C. L. Tissue distribution of C-14 after the intravenous injection of labeled free fatty acids and chylomicrons in nephrotic rats. J Clin Invest. 1962 Jan;41:185–195. doi: 10.1172/JCI104462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. MARSH J. B., DRABKIN D. L. Experimental reconstruction of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipemia. Metabolism. 1960 Oct;9:946–955. [PubMed] [Google Scholar]
  20. Marsh J. B., Sparks C. E. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis. J Clin Invest. 1979 Nov;64(5):1229–1237. doi: 10.1172/JCI109577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Marsh J. B., Sparks C. E. Lipoproteins in experimental nephrosis: plasma levels and composition. Metabolism. 1979 Oct;28(10):1040–1045. doi: 10.1016/0026-0495(79)90008-8. [DOI] [PubMed] [Google Scholar]
  22. McKenzie I. F., Nestel P. J. Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome. J Clin Invest. 1968 Jul;47(7):1685–1695. doi: 10.1172/JCI105859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nilsson-Ehle P., Schotz M. C. A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res. 1976 Sep;17(5):536–541. [PubMed] [Google Scholar]
  24. ROSENMAN R. H., BYERS S. O. Lipoprotein lipase metabolism in experimentally nephrotic rats. Proc Soc Exp Biol Med. 1960 Jan;103:31–36. doi: 10.3181/00379727-103-25402. [DOI] [PubMed] [Google Scholar]
  25. SAFFRAN J., KALANT N. Mechanisms of hyperlipemia in experimental nephrosis. J Clin Invest. 1959 Oct;38:1717–1724. doi: 10.1172/JCI103950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. SHAFRIR E. Partition of unesterified fatty acids in normal and nephrotic syndrome serum and its effect on serum electrophoretic pattern. J Clin Invest. 1958 Dec;37(12):1775–1782. doi: 10.1172/JCI103770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Scow R. O., Olivecrona T. Effect of albumin on products formed from chylomicron triacylclycerol by lipoprotein lipase in vitro. Biochim Biophys Acta. 1977 Jun 22;487(3):472–486. doi: 10.1016/0005-2760(77)90217-x. [DOI] [PubMed] [Google Scholar]
  28. Shafrir E., Biale Y. Effect of experimental hypertriglyceridaemia on tissue and serum lipoprotein lipase activity. Eur J Clin Invest. 1970 Mar;1(1):19–24. doi: 10.1111/j.1365-2362.1970.tb00592.x. [DOI] [PubMed] [Google Scholar]
  29. Sherrill B. C., Innerarity T. L., Mahley R. W. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. J Biol Chem. 1980 Mar 10;255(5):1804–1807. [PubMed] [Google Scholar]
  30. Sparks C. E., Marsh J. B. Analysis of lipoprotein apoproteins by SDS-gel filtration column chromatography. J Lipid Res. 1981 Mar;22(3):514–518. [PubMed] [Google Scholar]
  31. Sparks C. E., Marsh J. B. Metabolic heterogeneity of apolipoprotein B in the rat. J Lipid Res. 1981 Mar;22(3):519–527. [PubMed] [Google Scholar]
  32. Sparks C. E., Rader D. J., Marsh J. B. Metabolism of two forms of apolipoprotein B of VLDL by rat liver. J Lipid Res. 1983 Feb;24(2):156–166. [PubMed] [Google Scholar]
  33. Sparks C. E., Tennenberg S. D., Marsh J. B. Catabolism of apoprotein A-1 of HDL in normal and nephrotic rats. Metabolism. 1981 Apr;30(4):354–358. doi: 10.1016/0026-0495(81)90115-3. [DOI] [PubMed] [Google Scholar]
  34. Sparks C. E., Tennenberg S. D., Marsh J. B. Catabolism of the apolipoproteins of HDL in control and nephrotic rats. Biochim Biophys Acta. 1981 Jul 24;665(1):8–12. doi: 10.1016/0005-2760(81)90225-3. [DOI] [PubMed] [Google Scholar]
  35. Staprans I., Garon S. J., Hopper J., Jr, Felts J. M. Characterization of glycosaminoglycans in urine from patients with nephrotic syndrome and control subjects, and their effects on lipoprotein lipase. Biochim Biophys Acta. 1981 Dec 18;678(3):414–422. doi: 10.1016/0304-4165(81)90123-9. [DOI] [PubMed] [Google Scholar]
  36. Swaney J. B., Reese H., Eder H. A. Polypeptide composition of rat high density lipoprotein: characterization by SDS-gel electrophoresis. Biochem Biophys Res Commun. 1974 Jul 24;59(2):513–519. doi: 10.1016/s0006-291x(74)80010-0. [DOI] [PubMed] [Google Scholar]
  37. VAN HANDEL E., ZILVERSMIT D. B. Micromethod for the direct determination of serum triglycerides. J Lab Clin Med. 1957 Jul;50(1):152–157. [PubMed] [Google Scholar]
  38. Weisgraber K. H., Mahley R. W., Assmann G. The rat arginine-rich apoprotein and its redistribution following injection of iodinated lipoproteins into normal and hypercholesterolemic rats. Atherosclerosis. 1977 Oct;28(2):121–140. doi: 10.1016/0021-9150(77)90150-2. [DOI] [PubMed] [Google Scholar]
  39. Windmueller H. G., Wu A. L. Biosynthesis of plasma apolipoproteins by rat small intestine without dietary or biliary fat. J Biol Chem. 1981 Mar 25;256(6):3012–3016. [PubMed] [Google Scholar]
  40. Yamada M., Matsuda I. Lipoprotein lipase in clinical and experimental nephrosis. Clin Chim Acta. 1970 Dec;30(3):787–794. doi: 10.1016/0009-8981(70)90276-7. [DOI] [PubMed] [Google Scholar]
  41. ZLATKIS A., ZAK B., BOYLE A. J. A new method for the direct determination of serum cholesterol. J Lab Clin Med. 1953 Mar;41(3):486–492. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES